Although there were only marginal increases in intracellular GSSG levels ( P = 0.064), IL-13 increased extracellular (apical supernatant) GSSG ( P = 0.009), while lowering both GSH ( P = 0.012) and GSH:GSSG ( P = 0.006
According to the MHRA-approved Summary of Product Characteristics, the most frequently reported side effects include nausea (affecting approximately 40% of patients), vomiting, diarrhoea, constipation, dyspepsia (indigestion), and abdominal pain
Electrolyte imbalances due to fluid loss can cause muscle cramps, weakness, and an irregular heartbeat
Once I lost the weight, I saw that, if I am late to a doctors appointment, theyre more apologetic Oh, its no problem, she recounts
Side Effects Profile and Safety Considerations Common Gastrointestinal Effects The safety profile of GLP-1 medications is predominantly characterized by gastrointestinal adverse events ^6